Insider · CIK 0001812659
David S. Silberstein
Files at LTRN (Lantern Pharma Inc.). First filing -, latest -.
In brief
David S. Silberstein files SEC Form 4 as director at LTRN (Lantern Pharma Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David S. Silberstein has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jan 13, 2026 |
| Jan 9, 2026 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,307 | $0.00 | $0 | 17,307 | Jan 13, 2026 |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,135 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +9,135 | $0.00 | $0 | 9,135 | Sep 23, 2025 |
| Nov 4, 2021 | LTRN Lantern Pharma Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,200 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Nov 4, 2021 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,200 | $0.00 | $0 | 3,200 | Sep 23, 2025 |
Questions about David S. Silberstein
Answered from the filings on this page, as of the latest one.
Is David S. Silberstein buying or selling?
David S. Silberstein has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David S. Silberstein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David S. Silberstein has 0.
Where does David S. Silberstein file Form 4?
David S. Silberstein has filed Form 4 at LTRN (Lantern Pharma Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.